Medicare FFS ophthalmology
Provider service volume comparison
Compare two ophthalmology providers by CY2023 Medicare FFS service volume and CPT/HCPCS mix.
David Cupp, MD
NPI 1497901565 | Sacramento, CA
- National rank
- #207
- Total services
- 50,660
Choose provider
No provider selected.
Search providersCPT/HCPCS service volume comparison
Rows compare visible public provider-service lines by Medicare FFS service count.
| CPT/HCPCS | Description | Provider A services | Provider B services | Absolute difference | Higher Medicare FFS service volume |
|---|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 36,240 | 0 | 36,240 | Provider A higher |
| 92134 | Imaging of retina | 3,894 | 0 | 3,894 | Provider A higher |
| 92014 | Established patient complete exam of visual system | 2,264 | 0 | 2,264 | Provider A higher |
| J0178 | Injection, aflibercept, 1 mg | 2,158 | 0 | 2,158 | Provider A higher |
| 67028 | Injection of drug into eye | 2,005 | 0 | 2,005 | Provider A higher |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,688 | 0 | 1,688 | Provider A higher |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 405 | 0 | 405 | Provider A higher |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 310 | 0 | 310 | Provider A higher |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 285 | 0 | 285 | Provider A higher |
| 92004 | New patient complete exam of visual system | 245 | 0 | 245 | Provider A higher |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 140 | 0 | 140 | Provider A higher |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 128 | 0 | 128 | Provider A higher |
| 92250 | Photography of the retina | 120 | 0 | 120 | Provider A higher |
| J7999 | Compounded drug, not otherwise classified | 111 | 0 | 111 | Provider A higher |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 96 | 0 | 96 | Provider A higher |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 52 | 0 | 52 | Provider A higher |
| J3490 | Unclassified drugs | 46 | 0 | 46 | Provider A higher |
| 92012 | Established patient problem focused exam of visual system | 39 | 0 | 39 | Provider A higher |
| 67145 | Photocoagulation treatment to prevent detachment of retina | 37 | 0 | 37 | Provider A higher |
| 76512 | 2d ultrasound scan of eye tissue and structures | 35 | 0 | 35 | Provider A higher |
| 67108 | Repair of detached retina with drainage and removal of eye fluid between lens and retina | 27 | 0 | 27 | Provider A higher |
| 67515 | Injection of drug or substance into membrane covering eyeball | 23 | 0 | 23 | Provider A higher |
| 92002 | New patient problem focused exam of visual system | 22 | 0 | 22 | Provider A higher |
| 67228 | Destruction of leaking blood vessels of retina using laser | 19 | 0 | 19 | Provider A higher |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | 16 | 0 | 16 | Provider A higher |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 16 | 0 | 16 | Provider A higher |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 15 | 0 | 15 | Provider A higher |
| 67041 | Removal of membrane of retina | 13 | 0 | 13 | Provider A higher |
| 67040 | Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser | 12 | 0 | 12 | Provider A higher |